KRAS and non-small cell lung carcinoma: Sotorasib (AMG510), a covalent inhibitor of KRAS<sup>G12C</sup>, was recently approved for the treatment of KRAS<sup>G12C</sup>-mutated non-small cell lung cancer (NSCLC).